Antenatal Exposure and Diseases in the Offspring: The Role of Big Data Christoph R. MeierSusan S. Jick Commentary 10 February 2017 Pages: 363 - 364
Causality Assessment in Pharmacovigilance: Still a Challenge I. Ralph Edwards Current Opinion 28 February 2017 Pages: 365 - 372
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger? Rashmi R. Shah Review Article 09 February 2017 Pages: 373 - 386
Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort R. A. CharltonA. McGroganR. Bromley Original Research Article Open access 10 February 2017 Pages: 387 - 397
Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS Susan ColillaElad Yom TovJuhaeri Juhaeri Original Research Article 02 February 2017 Pages: 399 - 408
Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study Tim SchutteJelle TichelaarMichiel A. van Agtmael Original Research Article Open access 25 January 2017 Pages: 409 - 418
Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study Tim W. A. SchoenmakersMartina TeichertPeter A. G. M. de Smet Original Research Article Open access 15 February 2017 Pages: 419 - 430
Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification Igho J. OnakpoyaCarl J. HeneghanJeffrey K. Aronson Original Research Article 25 February 2017 Pages: 431 - 441
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study Sieta T. de VriesLisa WongIMI Web-RADR Work Package 3b Consortium Original Research Article Open access 29 December 2016 Pages: 443 - 455